喹诺酮类药物在治疗药物储备中的地位。
Place of quinolones in the therapeutic armoury.
作者信息
Van Klingeren B
出版信息
Pharm Weekbl Sci. 1986 Feb 21;8(1):40-1. doi: 10.1007/BF01975478.
PMID:3960692
Abstract
On the basis of antimicrobial activity, resistance development, pharmacokinetics, side effects and pre-clinical results, the applicability of the quinolones ciprofloxacin, enoxacin, norfloxacin, ofloxacin and pefloxacin is assessed. These quinolones seem especially useful in infections in hospitalized patients, in gonococcal infections and in urinary tract infections. Also salmonellosis and shigellosis might be indications for quinolones.
摘要
基于抗菌活性、耐药性发展、药代动力学、副作用及临床前研究结果，对喹诺酮类药物环丙沙星、依诺沙星、诺氟沙星、氧氟沙星和培氟沙星的适用性进行了评估。这些喹诺酮类药物似乎对住院患者感染、淋球菌感染及尿路感染特别有用。沙门菌病和志贺菌病也可能是喹诺酮类药物的适应证。
相似文献
1
Place of quinolones in the therapeutic armoury.喹诺酮类药物在治疗药物储备中的地位。
Pharm Weekbl Sci. 1986 Feb 21;8(1):40-1. doi: 10.1007/BF01975478.
2
Review of the 4-quinolones.
Infect Control. 1987 Mar;8(3):119-25. doi: 10.1017/s0195941700067291.
3
Quinolones.喹诺酮类
Prog Drug Res. 1987;31:243-56. doi: 10.1007/978-3-0348-9289-6_7.
4
The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans.氟喹诺酮类药物：人体药理学、临床应用及毒性
Antimicrob Agents Chemother. 1985 Nov;28(5):716-21. doi: 10.1128/AAC.28.5.716.
5
[In vitro activity of new quinolones against Mycoplasma pathogenic to humans].新型喹诺酮类药物对人致病性支原体的体外活性
Pathol Biol (Paris). 1988 May;36(5):496-9.
6
In vitro susceptibility of aerobic gram-negative blood culture isolates to oxolinic acid, norfloxacin, ciprofloxacin, enoxacin, pefloxacin, ofloxacin and oxo-enoxacin.需氧革兰氏阴性血培养分离株对恶喹酸、诺氟沙星、环丙沙星、依诺沙星、培氟沙星、氧氟沙星和氧恶喹酸的体外敏感性
Infection. 1986 May-Jun;14(3):142-4. doi: 10.1007/BF01643481.
7
Quinolones in vitro.
Pharm Weekbl Sci. 1986 Feb 21;8(1):26-8. doi: 10.1007/BF01975475.
8
Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.依诺沙星、环丙沙星、阿米氟沙星、诺氟沙星和氧氟沙星对177株细菌分离株的抗菌活性比较
J Antimicrob Chemother. 1986 May;17(5):623-8. doi: 10.1093/jac/17.5.623.
9
The comparative in-vitro activity of eight newer quinolones and nalidixic acid.八种新型喹诺酮类药物与萘啶酸的体外活性比较
J Antimicrob Chemother. 1986 Nov;18 Suppl D:1-20. doi: 10.1093/jac/18.supplement_d.1.
10
Symposium on antimicrobial agents. The quinolones.
Mayo Clin Proc. 1987 Nov;62(11):1007-12. doi: 10.1016/s0025-6196(12)65073-3.
本文引用的文献
1
Ciprofloxacin-resistant Staphylococcus aureus.
Lancet. 1985 Aug 17;2(8451):383. doi: 10.1016/s0140-6736(85)92510-3.
2
Resistance to ciprofloxacin.
Lancet. 1985 Jul 6;2(8445):39. doi: 10.1016/s0140-6736(85)90083-2.
Zotero 插件